Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A3 pseudogene 15 (HNRNPA3P15)

Target
HNRNPA3P15
Molecular classification
Other (pseudogene), Long non-coding RNA (lncRNA)
01

Overview

HNRNPA3P15 is a processed pseudogene located within the human genome that is related by sequence to the heterogeneous nuclear ribonucleoprotein A3 gene (HNRNPA3). Pseudogenes like HNRNPA3P15 arise via duplication or retrotransposition of functional genes but accumulate mutations or lack regulatory sequences needed for protein-coding function[3][5]. Most human pseudogenes are not transcribed or translated, though a minority are expressed as RNAs and a subset can be translated into short peptides[5]. There is currently no evidence that HNRNPA3P15 is transcribed or translated, nor that it plays any direct functional or pathogenic role. The parent gene, HNRNPA3, is a nuclear RNA-binding protein involved in mRNA processing, transport, and splicing, with an established association with cancer biology[2][4]. HNRNPA3P15 itself is not a recognized drug target, receptor, or enzyme, and should be excluded from therapeutic target databases.

Other names
HNRNPA3P15
02

Mechanism of action

Not applicable; the molecule is a pseudogene and is not known to be the direct target of any drugs.

03

Biological functions

None directly assigned; pseudogenes generally do not have direct biological functions, but some transcribed pseudogenes may regulate gene expression through RNA-based mechanismsIf transcribed, may act via regulation of parent gene or as a competing endogenous RNA (theoretical for this class)No evidence for canonical roles such as RNA binding, splicing, or cell signaling for HNRNPA3P15 itself—but these are associated with the parent HNRNPA3 gene
04

Disease associations

None directly assigned for HNRNPA3P15.HNRNPA3 (parent gene) involved in cancer, particularly hepatocellular carcinoma, via regulation of splicing, cell differentiation, and cell cycle
05

Safety considerations

Not applicable. HNRNPA3P15 is not a direct drug target.
06

Interacting drugs

None known for HNRNPA3P15.
07

Biomarkers

Not applicable for HNRNPA3P15.HNRNPA3 (parent gene) expression is a proposed diagnostic/prognostic biomarker in hepatocellular carcinoma

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 15 (HNRNPA3P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 15 (HNRNPA3P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call